CLINICAL_TRIALS
research
· 2026-02-27
Clinical Trial Update: 177Lu-CTR-FAPI for the Treatment of Thyroid Cancer [Phase 1]
Summary
A Phase 1 clinical trial evaluating 177Lu-CTR-FAPI for thyroid cancer is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SHAOYAN LIU | Conditions: Thyroid Cancer | Phase 1 | Status: RECRUITING